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A gastrin transcript expressed in gastrointestinal cancer cells
contains an internal ribosome entry site
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As the hormone gastrin promotes gastrointestinal (GI) cancer progression by triggering survival pathways, regulation of gastrin
expression at the translational level was explored. Sequence within the 50 untranslated region of a gastrin transcript expressed in GI
cancer cells was investigated, then cloned into a bicistronic vector upstream of firefly luciferase and transfected into a series of GI
cancer cell lines. Firefly luciferase activity was measured relative to that of a cap-dependent Renilla luciferase. A gastrin transcript that
was different from that described in Ensembl was expressed in GI cancer cells. Its transcription appears to be initiated within the
region designated as the gene’s first intron. In GI cancer cells transfected with the bicistronic construct, firefly luciferase activity
increased 8–15-fold compared with the control vector, and there was a further induction of the signal (up to 25-fold) following
exposure of the cells to genotoxic stress or hypoxia, suggesting that the sequence acts as an internal ribosome entry site. These data
suggest that the gastrin transcript within GI cancer cells contains an internal ribosome entry site that may allow continued expression
of gastrin peptides when normal translational mechanisms are inactive, such as in hypoxia, thereby promoting cancer cell survival.
British Journal of Cancer (2008) 98, 1696–1703. doi:10.1038/sj.bjc.6604326 www.bjcancer.com
Published online 8 April 2008
& 2008 Cancer Research UK
Keywords: gastrin; translation; gastrointestinal; internal ribosome entry
                                           
Gastrin is normally expressed in G cells of the stomach antrum and
regulates both acid secretion and proliferation of gastric mucosal
cells (Watson et al, 2006). The gastrin gene (GAST) is a 4-kb unit
consisting of three exons and two introns with the gastrin
polypeptide encoded by sequence within exons 2 and 3 (http://
www.ensembl.org/index.html). Two different gastrin transcripts
have been described in the literature. The transcript given in the
Ensembl database was described in human gastrinomas and is a
434-bp transcript incorporating sequence from exon 1 (Ito et al,
1984; Wiborg et al, 1984). However, another transcript was
identified in the gastric antrum that has a transcription start site
111bp upstream of the start codon (Kato et al, 1983). Thus, the 50
untranslated regions (50UTRs) of the Ensembl and alternative
transcripts are different.
Gastrin upregulation has been shown at both the gene and
protein levels in a number of gastrointestinal (GI) (Goetze et al,
2000; Mukawa et al, 2005; Hur et al, 2006) and non-GI cancers
(Rehfeld et al, 1989; van Solinge et al, 1993). At the transcriptional
level in GI cancer, gastrin upregulation may be a result of
mutational events, for example in the APC (adenomatous
polyposis coli) or k-ras genes (Nakata et al, 1998; Koh et al,
2000); engagement of the EGF (epidermal growth factor) receptor
(Merchant et al, 1991); inflammatory events mediated directly by
cytokines, such as those associated with Helicobacter pylori
infection (Suzuki et al, 2001; Beales, 2004); or direct activation
by certain pathogenicity factors expressed by Helicobacter pylori
(Rieder et al, 2005).
Expression of a number of genes that promote cancer cell
survival has been shown to be regulated at the translational level
(Pickering and Willis, 2005; Sontheimer and Carthew, 2005). One
mechanism, involving the presence of an internal ribosome entry
site (IRES) within the 50UTR of the transcript, may have evolved to
allow continued expression of key proteins involved in cell survival
during cellular stress (Bushell et al, 2004; Holcik and Sonenberg,
2005) when conventional cap-mediated translation is reduced.
However, it may also contribute to cancer cell survival as IRESs
have been identified in the transcripts of genes that increase
proliferation, protect against apoptosis and promote angiogenesis
(Vagner et al, 1995; Miller et al, 1998; Stoneley et al, 2000a;
Coldwell et al, 2001).
Gastrin plays an important role in establishing and supporting
the growth of a range of GI tumours (Ferrand and Wang, 2006;
Watson et al, 2006). As well as acting as a growth hormone, it has
well-documented pro-angiogenic (Clarke et al, 2006) and anti-
apoptotic properties (Konturek et al, 2003; Harris et al, 2004;
Ramamoorthy et al, 2004). We have previously used RNAi to
downregulate gastrin expression at the gene level and observed a
rapid loss of the transcript, but also a delayed downregulation of
the endogenous protein compared with GFP-tagged gastrin
encoded by a transcript lacking the gastrin 50UTR (Grabowska
et al, 2007). This raised the possibility that gastrin expression may
be regulated translationally in a manner dependent on the 50UTR
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sallowing continued protein expression from the small amount of
transcript remaining in the cells following RNAi-mediated knock-
down. Therefore, we investigated the 50UTR of the gastrin
transcript for sequences that might regulate gastrin expression at
the translational level in GI cancer.
MATERIALS AND METHODS
Cell culture
PAN1 is a human pancreatic cell line derived from a poorly
differentiated human pancreatic adenocarcinoma within the
Division of Pre-Clinical Oncology, University of Nottingham
(UK). HCT116, a poorly differentiated human colon cell line, was
obtained from ECACC (reference no. 91091005). All cell lines were
routinely cultured in RPMI 1640 culture medium (Gibco, Paisley,
UK) containing 10% (v/v) heat-inactivated fetal bovine serum
(FBS; Sigma, Poole, UK) at 371Ci n5 %C O 2 and humidified
conditions.
RNA ligase-mediated rapid amplification of cDNA ends
RNA was extracted from PAN1 cells using RNABee (Biogenesis,
Poole, UK) and quantified using an ND-100 Spectrophotometer
(Nanodrop, Wilmington, USA). Analysis of the 50 ends of the
gastrin transcripts was carried out using the RLM-RACE kit,
according to the manufacturer’s instructions (Ambion, Cambs,
UK). The sequences of the primers used are given in Table 1.
Briefly, 3mg of total RNA was treated with calf intestine alkaline
phosphatase for 1h at 371C (to remove free 50 phosphate groups),
phenol-chloroform extracted, isopropanol precipitated, then trea-
ted with Tobacco Acid Pyrophosphatase for 1h at 371C to remove
the 50 cap. A rapid amplification of cDNA ends (RACE) adapter
was ligated to the product using T4 RNA ligase, and cDNA
synthesis carried out using random decamers and M-MLV Reverse
Transcriptase. A nested polymerase chain reaction (PCR) was
carried out using the cDNA as a template. In the first round, the
50 RACE outer primer was used with the gastrin RACE outer
primer. In the second round, the 50 RACE inner primer was used
with the gastrin RACE inner primer.
TA cloning
The PCR products from the RNA ligase-mediated rapid amplifica-
tion of cDNA ends (RLM-RACE) nested PCR were cloned into
pCRII-TOPO using the TOPO TA cloning kit (Invitrogen, UK) and
transformed into TOP10F0 competent cells (Invitrogen). Clones
containing inserts were selected by blue-white screening and DNA
prepared using Genelute plasmid miniprep kits (Sigma). The DNA
was sequenced using a T7 primer and BigDye reaction mix and
analysed using an ABI 310 Genetic Analyser (ABI, Warrington,
UK). Similarity between the RLM-RACE products and the gastrin
gene and transcript sequences obtained from Ensembl Genome
Browser (http://www.ensembl.org/index.html) was compared
using the ClustalW program in Biology Workbench (http://
workbench.sdsc.edu/). The sequence was also submitted to
UTRScan (http://www.ba.itb.cnr.it/BIG/UTRScan/).
Reverse transcriptase-PCR (RT-PCR)
To detect expression of gastrin transcripts, RNA was extracted
using the PARIS mirVana kit (Ambion) using the protocol for
‘large’ RNA, then reverse transcribed into cDNA using the
Quantitect Reverse Transcription kit (Qiagen, Sussex, UK), which
includes a step for removal of genomic contamination. For each
RNA, a duplicate reaction was carried out omitting the reverse
transcriptase (RT) to ensure that all genomic contamination had
been removed. A 2ml aliquot of the cDNA or ‘RT minus’ control
was amplified using a primer specific for the Ensembl transcript
(GasEnsF) or the alternative transcript (GasAltF) in combination
with a common reverse primer (HGASL). The sequences of the
primers are given in Table 1. A 10ml aliquot of the PCR reaction
was analysed on a 2% agarose gel alongside 2-log markers (New
England Biolabs, Herts, UK) and visualised using ethidium
bromide staining.
To investigate the size of transcripts synthesised from the
bicistronic constructs, RNA was prepared using RNABee as
described above and cDNA synthesised using Superscript II and
random hexamers as described previously (McWilliams et al,
1998). To ensure that signals generated were derived from RNA,
RT-negative, cDNA reagent and extraction controls were included
in which the RT was omitted from the cDNA synthesis, RNA was
omitted from the cDNA synthesis or cells were omitted from the
RNA extraction. Polymerase chain reaction was carried out using
forward and reverse primers located within the Renilla and firefly
luciferases, respectively, to determine the size of the transcript
generated from the plasmid. The sequences of the primers are
given in Table 1.
Reporter construct cloning
The putative gastrin IRES was PCR amplified using forward and
reverse primers (EcoRI GasIRESF and NcoI GasIRESR) designed to
contain EcoRI and NcoI restriction enzyme sites, respectively
(shown in lower case in the primer sequences given in Table 1) to
facilitate cloning. In the reverse primer, the NcoI site was designed
to lie over the gastrin start codon, which involved making
mutations in the sequence (shown in Table 1 by underlining of
altered nucleotides) to create the restriction enzyme site. Following
restriction digestion of the PCR product with EcoRI and NcoI, the
fragment was cloned into the bicistronic reporter construct, pRF
(Stoneley et al, 2000b). This construct contains the Renilla
luciferase gene downstream of an SV40 promoter and the firefly
luciferase gene downstream of a cloning site that contains EcoRI
and NcoI restriction sites. It was also cloned into pBR (Mitchell
et al, 2005), which lacks a viral promoter. Constructs designated
pRGasF and pBRGas were generated. Constructs containing the
c-myc IRES (pRMF) and pBRMyc were used as controls (Stoneley
et al, 2000b).
Transfections
Transfections were carried out using Lipofectamine 2000
(Invitrogen, Paisley, UK). Test plasmids were co-transfected with
a control plasmid (Coldwell et al, 2000), encoding b-galactosidase
(b-gal) to provide a transfection control, using a ratio of 5:1, test
Table 1 Primer sequences
Primer Sequence
RACE adapter GCUGAUGGCGAUGAAUGAACACUGCGUUU
GCUGGCUUUGAUGAAA
50 RACE outer primer GCTGATGGCGATGAATGAACACTG
Gastrin RACE outer primer TCCAGCCAGGGTAGCTCCAG
50 RACE inner primer CGCGGATCCGAACACTGCGTTTGCTGGCT
TTGATG
Gastrin RACE inner primer GGCTTCCAAGAAGCTTCAGA
GasEnsF CCACACACCTCCCAGCTC
GasAltF TGGAGCCACATGGTTCAGT
HGASL TCCATCCATCCATAGGCTTC
EcoRI GasIRESF CCGCCGgaattcAGGCCTAGAGCCACATGGT
NcoI GasIRESR ACACACACAGTCGCTccatggCGTCTGCAA
Renilla luciferase F GCAAGAAGATGCACCTGATG
Firefly luciferase R GCGTATCTCTTCATAGCCTT
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splasmid: b-gal plasmid. Following initial optimisation experiments
500ng of plasmid was used to transfect 2 10
5 cells in 24-well
plates. A 500ng aliquot of test plasmid plus 100ng of b-gal plasmid
were diluted to 50ml in Optimem (Gibco BRL), mixed with 2ml
Lipofectamine 2000 (diluted to 50ml in Optimem) for 20min at
room temperature, and added to cells in 500ml culture medium. To
measure basal IRES activity, cells were incubated for 24h before
harvesting. To investigate the activity of the IRES following
treatment with mitomycin C (MMC; Sigma) or exposure to
hypoxia, medium was changed 6h after transfection and either
normal culture medium, medium containing 2–20mgml
 1 MMC
or serum-free medium was added. The cells were then returned to
the CO2 incubator or exposed to hypoxia (1% oxygen, 5% CO2,
371C) using an Invivo2 400 Hypoxia workstation (Biotrace Fred
Baker, Bridgend, UK) for a further 24h.
Dual transfection of plasmids and siRNAs was carried out by
preparing the plasmid transfection mix as above but in half the
volume, and preincubating 500ng of siRNA with 1ml siPortAmine
(Invitrogen) in 25ml serum-free medium. The two transfection
reagents were then mixed immediately before addition to the cells.
The Renilla siRNA had the target sequence AACGCGGCCTC
TTCTTATTTA, which was designed using the Qiagen siRNA
Design tool and has a perfect match with Renilla luciferase, but
nine mismatches and a maximum of six adjacent matching
nucleotides when aligned with the sequence of firefly luciferase.
Reporter assays
Cells were harvested and analysed using the Stop and Glo
luciferase assay (Promega). Cells were lysed in PLB buffer
(Promega) and both firefly and Renilla luciferase activity
measured using a MicroLumi XS luminometer (Harta Instruments,
Gaithersburg, Maryland, USA). b-Gal activity was measured using
the Galacto-Light Plus system (ABI). All luciferase readings were
expressed relative to the b-gal activity in the same sample.
Statistics
The Student t-test was used to compare luciferase activity in cells
transfected with IRES constructs vs control vectors or exposure to
hypoxia vs normoxia. The effect of treatment with increasing
concentrations of MMC was analysed using one-way ANOVA with
Dunnett’s multiple comparison test, with Po0.05 considered
significant.
RESULTS
The gastrin transcript identified by RLM-RACE does not
contain the 50UTR of the transcript defined by Ensembl
The sequence of the 50UTR of gastrin transcripts isolated from the
pancreatic cell line, PAN1, was analysed by RLM-RACE using two
gastrin-specific primers, one in each round of PCR, paired with
primers specific for the 50 adapter sequence. The PCR products
were cloned and eight individual clones sequenced. Three unique
clones were identified (1, 2 and 7); the remaining clones were
identical to clone 2. The sequences of clones 1, 2 and 7 were
aligned with the gastrin genomic sequence, the sequence of the
50UTR of the gastrin transcript provided by Ensembl and the
50UTR of the transcript described by Kato et al (1983) (GenBank
entry, X00183). The alignment is shown in Figure 1. There was only
a small region of high homology with the 50UTR of the Ensembl
transcript consisting of 10 nucleotides (indicated in Figure 1 by B)
derived from the end of exon 1 (5 nucleotides) and the beginning
of exon 2 (5 nucleotides). However, there was a high degree of
homology with the sequence defined by Ensembl as intron 1 and
the 50UTR of the transcript defined in GenBank entry X00183, with
differences only at two positions (indicated by ^ in Figure 1); the
Ensembl genomic sequence and the RLM-RACE clones all have a
T at position  88, which is missing in X00183 and, in addition, the
RLM-RACE clones represented by clones 2 and 7 have a G/T
substitution at  66. For six of the clones (represented by clone 2 in
Figure 1) and in clone 7, the sequence started at a point 106bp
upstream of the ATG codon; for clone 1 the start point was at
 122. Thus, the transcript identified by RLM-RACE in the PAN1
cells is different from the gastrin transcript described in Ensembl
and more closely resembles that described in GenBank entry,
X00183.
The transcript identified by RLM-RACE is expressed in a
range of GI cancer cells
RT-PCR was carried out in a panel of GI cancer cells using primers
specific for the 50UTR of the Ensembl transcript or the alternative
transcript in combination with a common primer (Figure 2). Both
transcripts were present in all the cell lines tested, which included
cells of pancreatic, colonic, gastric and oesophageal origin. For the
alternative transcript, two amplification products were observed: a
band of the predicted size of 360bp in all of the cell lines except for
        Exon 1                       Intron 1 
        *                            * 
Genomic  GGCACCACAC ACCTCCCAGC TCTGCAGGTG AGAAAACCCA .......... 
Ensembl  GGCACCACAC ACCTCCCAGC TC-------- ---------- .......... 
X00183  ---------- ---------- ---------- ---------- .......... 
     1  ---------- ---------- ---------- ---------- .......... 
     2  ---------- ---------- ---------- ---------- .......... 
     7  ---------- ---------- ---------- ---------- .......... 
Genomic  CTGCACTCCA GCCTGGGCAA CAAGAGTGAA ACTCTGTCTA AAAAAAAAAA 
Ensembl  ---------- ---------- ---------- ---------- ---------- 
X00183  ---------- ---------- ---------- ---------- ---------- 
     1  ---------- ---------- ---------- ---------- ---------- 
     2  ---------- ---------- ---------- ---------- ---------- 
     7  ---------- ---------- ---------- ---------- ---------- 
                      ^ 
Genomic  AAAGAAAGAA TTGCACACTC ATCAGCAGGT AGAGGCCTGG AGCCACATGG 
Ensembl  ---------- ---------- ---------- ---------- ---------- 
X00183  ---------- ----ACACTC ATCAGCAGGT AGAGGCCTAG AGCCACATGG 
     1  ---GAAAGAA TTGTACACTC ATCAGCAGGT AGAGGCCTGG AGCCACATGG 
     2  ---------- ---------C ATCAGCAGGT AGAGGCCTGG AGCCACATGG 
     7  ---------- ---------C ATCAGCAGGT AGAGGCCTGG AGCCACATGG 
                   ^ 
Genomic  TTCAGTCCCC TGCCTCTGGG CCTCTGTGGG GACAGCCTCA CCCTTAAGCT 
Ensembl  ---------- ---------- ---------- ---------- ---------- 
X00183  TTCAGTCCCC -GCCTCTGGG CCTCTGTGGG GACAGCCTCA CCCTTAAGCT 
     1  TTCAGTCCCC TGCCTCTGGG CCTCTGTGGG GACAGCCTCA CCCTTAAGCT 
     2  TTCAGTCCCC TGCCTCTGGG CCTCTGTGGG GACAGCCTCA CCCTTAAGCT 
     7  TTCAGTCCCC TGCCTCTGGG CCTCTGTGGG GACAGCCTCA CCCTTAAGCT 
     Exon  2 
    ^    * 
Genomic  AGTCCCTTCT CCCCTTTGCA GACGAGATG 
Ensembl  ---------- ------TGCA GACGAGATG 
X00183  AGTCCCTTCT CCCCTTTGCA GACGAGATG 
     1  AGTCCCTTCT CCCCTTTGCA GACGAGATG 
     2  AGTCCCTTCT CCCCGTTGCA GACGAGATG 
     7  AGTCCCTTCT CCCCGTTGCA GACGAGATG 
                         ~~~~ ~~~~~~ 
Figure 1 Alignment of Ensembl gastrin genomic sequence (Genomic),
Ensembl gastrin transcript (Ensembl), GenBank sequence X00183
(X00183) and three representative RLM-RACE clones (1, 2 and 7).
Clones 1 and 7 occurred once each, and clone 2 occurred six times. The
beginning of exon 1, intron 1 and exon 2 are indicated by * and the ATG
start codon is highlighted in bold. The central 2860bp of intron 1 have
been omitted for clarity and their position is indicated by --------; only
sequence of the first 13-bp and final 171-bp of intron 1 are shown. The
RLM-RACE clones have high homology with the region defined by Ensembl
as intron 1 and with X00183; ^ indicates positions where one of the clones
or X00183 did not match the genomic sequence. There were only 10
nucleotides, which matched the Ensembl transcript, indicated by B below
the sequence. The UTRScan-predicted IRES within X00183 is highlighted
by shading.
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sMGLVA1 cells and a higher molecular weight product of 490bp in
all of the cell lines except HCT116 and C170HM2 cells. The size of
this larger product equates to the expected transcript but with the
intron 2 retained. However, this does not appear to be derived
from amplification of contaminating genomic DNA as it did not
appear in the RT-negative control.
Prediction of an IRES within the gastrin transcript
identified by RLM-RACE
The 50UTR of the transcript identified in the GI cancer cells by
RLM-RACE is GC-rich, with a 60.7% GC content and includes an
AUG upstream of the translation start site. Therefore, we analysed
the sequence for elements that might regulate the stability of the
transcript or its translation. The sequences of the 50UTRs of the
gastrin transcript identified by RLM-RACE, the Ensembl transcript
and the transcript described in X00183 were submitted to
UTRScan. An IRES, consisting of 91bp of sequence upstream of
the start codon, was predicted to be present only in the X00183
gastrin transcript (sequence shaded in Figure 1), in spite of the
homology between the X00183 transcript and that identified by
RLM-RACE, the RLM-RACE transcript differing only by the
inclusion of one additional T at  66.
Assessment of the activity of the putative IRES to regulate
translational activity
To assess the ability of the putative IRES to regulate translation a
bicistronic reporter vector, pRF was used, consisting of two
luciferase genes encoded within a single transcript expressed under
the control of an SV40 promoter. The predicted IRES was
amplified and cloned into pRF to generate a construct pRGasF.
The sequence of two clones was compared with the sequence of the
transcript predicted in X00183. The additional T nucleotide at
position  66 was found to be present in both clones, as expected
from the RLM-RACE data; in addition, some minor differences
were found at positions  1/2 and  96/97.
The 50 Renilla luciferase in the bicistronic vector was designed
so it would be translated in a cap-dependent manner but
translation of the 30 firefly luciferase would be dependent on the
insertion of an IRES. For each construct, the activity of the IRES-
dependent luciferase was measured relative to the empty vector
and cap-dependent luciferase signal in Pan1 and HCT116 cells.
There were significant 8- and 15-fold increases (P¼0.02 and
Po0.001) in luciferase activity in PAN1 and HCT116 cells,
respectively, following insertion of the putative gastrin IRES
(pRGasF). A construct containing the c-myc IRES (pRMF) was
included as a positive control in these experiments (Figure 3A
and B). The activity of this IRES was particularly high in PAN1
cells with a 49-fold induction of activity (P¼0.014) but, in HCT116
cells, the activity was similar to that of the gastrin IRES, with a
10-fold increase compared with the empty vector, pRF (P¼0.007).
The putative gastrin IRES has no activity in a plasmid
lacking a promoter
To verify that the putative gastrin IRES is not acting as a promoter
in pRGasF, it was cloned into a reporter vector, pBR, lacking a viral
promoter but with viral enhancer elements still present down-
stream of the firefly luciferase. There was no increase in luciferase
activity in the pBR construct when the putative gastrin IRES was
inserted (pBRGas), suggesting that the sequence is not able to act
as a promoter, even in the presence of viral enhancer sequences
while activity of the pRGasF IRES construct was as expected
(Figure 3C). In addition, when a Renilla siRNA was used to treat
the pRGasF-transfected cells, there was a significant knockdown of
the firefly luciferase activity in parallel with the knockdown of the
Renilla activity (Po0.005 for both), suggesting that both are
encoded on the same transcript (Figure 3D), and RT-PCR of RNA
from pRGasF-transfected cells using primers located within the
Renilla and firefly luciferases, respectively, revealed a single band
of approximately 300bp (Figure 3E), which equates to a full-length
RNA without smaller splice variants.
The activity of the putative gastrin IRES is upregulated
following exposure of the cells to genotoxic stress or
hypoxia
Since a role for gastrin in promoting cell survival has been shown,
the activity of the IRES was studied after exposure of HCT116 and
PAN1 cells transfected with pRGasF to a range of concentrations of
the DNA-damaging agent, MMC. As expected, with increasing
concentrations of MMC, activity of the cap-dependent luciferase
was switched off (Figure 4A). However, activity of the IRES-driven
luciferase was either maintained or increased resulting in an
increase in the ratio of firefly to Renilla luciferase activity in both
cell lines (Figure 4B and C). This suggests that the putative gastrin
IRES is able to support translation under circumstances where
cap-dependent translation is not functional.
Gastrin is also known to promote angiogenesis, and so we
investigated the effect of hypoxia on IRES-driven luciferase
activity. The effect of serum was incorporated into this study as
the activity of the HIF IRES has previously been shown to be most
active in serum-free conditions. In HCT116 cells, there was a
significant increase in the relative activity of the IRES-driven
compared with the cap-driven luciferase after 24h exposure to
hypoxia in the presence of serum (P¼0.016). There was also an
increase in the absence of serum, but this did not reach statistical
significance (P¼0.078).
DISCUSSION
We have shown that a gastrin transcript expressed in a panel of GI
cancer cell lines contains an IRES that has basal activity in both
pancreatic and colon cancer cells. The sequence appears to be
acting as a true IRES, as activity is lost in the absence of a viral
promoter. Under conditions of cellular stress, activity of the IRES
is increased or maintained at higher levels than cap-dependent
translation suggesting that it is controlled by a distinct mechanism,
as shown for the c-myc IRES (Subkhankulova et al, 2001).
The IRES-containing transcript found in the GI cancer cell lines
appears to use a transcription start site within the sequence
assigned by Ensembl as intron 1 and is homologous to the
transcript described in G cells (Kato et al, 1983). These authors
localised a possible transcription start site by S1 nuclease mapping,
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Figure 2 Reverse transcriptase-PCR to investigate expression of the two
gastrin transcripts in a panel of GI cancer cell lines: (1) PAN1, (2) BXPC3
(pancreatic); (3) HCT116, (4) HT29 (5) C170HM2 (colonic); (6) ST16, (7)
MGLVA1 (gastric); (8) OE19 and (9) OE21 (oesophageal). cDNA (þ) and
a negative control in which the RT was omitted ( ) were amplified using a
primer specific for each transcript ((A) alternative transcript and
(B) Ensembl transcript) and a common primer. The expected position of
the bands is indicated by an arrow based on the position of the 100-bp
markers (M).
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sfollowing hybridisation with gastric antrum polyA RNA, to
approximately 111bp upstream of the start codon. Potential
Goldberg-Hogness and CCAAT boxes were found upstream of
the transcription start site in the 50 flanking DNA sequence
(Kato et al, 1983).
Seven of the independent clones generated by RLM-RACE
started 106bp upstream of the ATG start codon and the remaining
clone started a further 16bp upstream. It is unlikely that the
products arise from amplification of DNA fragments; such
fragments arise at random and are unlikely to have 50 ends, which
cluster at a single location. In addition, RLM-RACE is designed to
prevent amplification of DNA templates; it includes steps which
remove free 50 phosphates from uncapped RNAs and contamina-
ting DNA, preventing ligation of the adapter to such nucleic acids,
and no product was detected when the enzyme TAP, which
removes the cap to reveal the free 50 phosphate on mRNA and
allow ligation of the adapter, was omitted.
In addition, using RT-PCR, the alternative transcript was shown
to be present in all of the GI cancer cell lines investigated including
cells of pancreatic, colonic, gastric and oesophageal origin. An
amplification product with a higher molecular weight than that
predicted was also amplified in most of the GI cancer cell panel
using a primer specific for the alternative transcript; this appears
to have retained intron 2 and further investigation will be required
to determine how this transcript arises and whether it is
functional. However, the predicted transcript was also present in
the majority of the cell lines investigated; while the intensity of the
band derived from the Ensembl transcript was fairly uniform
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Figure 3 Activity of the putative gastrin IRES and Myc IRES in pancreatic (PAN1) and colon (HCT116) cancer cell lines. Basal activity of (A) the gastrin
IRES (pRGasF) or (B) Myc IRES (pRMF) compared with empty vector (pRF). (C) Activity of the gastrin IRES in a promotorless plasmid (pBRGas) compared
with the empty vector (pBR) or pRGasF. (D) Significant knockdown of both Renilla and firefly luciferase activity in HCT116 cells transfected with pRGasF and
a Renilla siRNA, compared with cells transfected with pRGasF and a control siRNA (Po0.005 for both). (E) Reverse transcriptase-PCR of cells transfected
with pRGasF using forward and reverse primers located within the Renilla and firefly luciferase sequences. A single band of B300bp was observed (Lane 1).
No bands were observed in the RT-negative, cDNA reagent and RNA isolation controls (Lanes 2–4). Lane 5: markers. Statistical significance is indicated by
*Po0.05 or **Po0.01.
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sacross the cell line panel, the intensity of the bands from the
alternative transcript varied between cell lines.
This raises the question of how transcription of these two
mRNAs is regulated. Most studies investigating regulation of
gastrin gene transcription in GI cancer cells have used constructs
based on the promoter associated with the Ensembl transcript.
Further studies to investigate the DNA flanking sequence will be
required to identify the promoter, that drives transcription of this
alternative mRNA. Transcription from alternative start sites has
been shown previously in certain genes, including oncogenes,
giving rise to transcripts that are differentially regulated at the
translational level; for example, c-myc has four alternative
transcripts driven by different promoters and only one of these
contains an IRES (Marcu et al, 1992).
The 50UTR of the alternative gastrin transcript described in the
present study is GC-rich, in keeping with other described IRESs,
which are generally highly structured (Pickering and Willis, 2005).
Since the function of IRESs is probably dependent on their three-
dimensional structure rather than the presence of specific
sequences, it has been difficult to identify motifs that allow their
definitive identification. A recent paper has identified a motif,
(CCU)n occurring within a polypyrimidine tract, which acts as an
artificial IRES when the polypyrimidine tract protein, one of the
trans-acting factors thought to be involved in initiation of
translation from IRESs, is present (Mitchell et al, 2005). We used
a bioinformatics-based method to look for common functional
sequences that occur in the UTRs of transcripts (Pesole and Liuni,
1999), which includes a search for a motif common to IRESs of
cellular RNAs that forms a Y-type stem loop structure (Le and
Maizel, 1997). Interestingly, while UTRScan identified a potential
94-bp IRES within the 50UTR of the transcript described in
GenBank entry X00183, it did not identify an IRES within the
50UTR of the transcript identified by RLM-RACE, which differs
only by insertion of a single nucleotide 66bp upstream of the start
codon, showing that such programs can only be used to provide
guidance.
Therefore, we tested the ability of the predicted IRES to drive
translation within a bicistronic reporter construct (Stoneley et al,
1998; Coldwell et al, 2001; Mitchell et al, 2001). There was
significant IRES-dependent activity in both of the GI cancer cell
lines used. In PAN1 cells, the IRES-driven luciferase activity was
lower than that observed using a construct containing the c-myc
IRES. In HCT116 cells, while the activity of the gastrin IRES was
lower than in PAN1 cells, it was higher than that of the c-myc IRES
in these cells. For these experiments, we inserted only the 94-bp
sequence, which was predicted to be an IRES by UTRScan and
used the sequence variant found in the PAN1 gastrin transcript. It
is possible that the removal of the inserted T and use of the whole
of the transcript’s 50UTR might lead to a higher level of activity.
The luciferase activity observed when the gastrin 50UTR
sequence was inserted into the bicistronic construct might occur
because the sequence is able to act as a promoter and allow
independent transcription of the downstream luciferase. However,
when the gastrin sequence was cloned upstream of luciferase in a
vector that did not contain a promoter, there was no luciferase
activity compared with the empty vector. This is further suggested
by the reduction in firefly luciferase activity observed in parallel
with the reduction in Renilla luciferase activity following treatment
with a Renilla luciferase-specific siRNA. Another possible
explanation for the activity of the luciferase downstream of the
putative gastrin IRES is that the sequence acts as a splice acceptor,
as has been suggested for the XIAP sequence (Van Eden et al,
2004), but we did not observe any smaller RT-PCR products to
indicate that the IRES sequence was being removed by splicing.
Taken together, these data suggest that the gastrin sequence is
acting as an IRES.
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Figure 4 Effect of MMC and hypoxia on IRES activity. Treatment with MMC significantly reduced cap-dependent translation of the Renilla luciferase (A)
but resulted in an increase in the ratio of IRES-dependent to cap-dependent translation in both HCT116 (B) and PAN1 cells (C). Similarly, 24h exposure to
a hypoxic environment increased IRES-dependent translation (D). Statistical significance is indicated by *Po0.05 or **Po0.01.
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sUnder conditions of cellular stress, for example apoptosis, cap-
dependent translation is switched off as a result of cleavage of
initiation factors such as EIF4G and EIF4B, which prevents
circularisation of the transcript (Spriggs et al, 2005). Expression
of genes that play an anti-apoptotic role in cancer has been shown
to be maintained via use of an IRES (Coldwell et al, 2001), and
since such a role has also been ascribed to gastrin in GI cancer cells
(Harris et al, 2004), we investigated whether the gastrin IRES was
active during apoptosis induced by the genotoxic agent, MMC.
Gastrin also has a role in promoting angiogenesis and so, in
parallel, we investigated the effect of hypoxia on the gastrin IRES
activity. In both cases, activity of the IRES was increased relative to
cap-dependent translation.
The translation initiation factors that regulate expression from
IRESs have begun to be elucidated. They appear to include
canonical translation initiation factors such as eIF2, eIF3 and eIF4F
(Pestova et al, 1996) and also other trans-acting factors, and may
act to change the secondary structure of the IRES to facilitate
ribosomal binding (Mitchell et al, 2003; Pickering et al, 2004).
Differential expression of such factors may explain the different
patterns of activity of individual IRESs during development and
differentiation (Sella et al, 1999; Creancier et al, 2000; Mitchell
et al, 2003) and in cancer (Evans et al, 2003). In the present study,
the basal activity of the c-myc and gastrin IRESs in PAN1 and
HCT116 cells, which are of pancreatic and colonic origin, did not
correlate. In addition, the activity of the c-myc IRES, which has
previously been shown to be upregulated by MMC in HeLa cells
(Subkhankulova et al, 2001), was not increased following exposure
of these GI cancer cells to MMC, but it was responsive to hypoxia
(data not shown). Taken together, these data suggest that
expression from the two IRESs is controlled independently,
involving different trans-acting factors.
Expression of a transcript containing an IRES, which allows
continued expression of gastrin peptides in the face of apoptotic
stimuli or hypoxia would promote the survival of GI cancer cells.
Thus, further investigation of the mechanisms regulating expres-
sion of the transcript and activity of the IRES in different cell types
is warranted.
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